Galen Partners is a private equity firm that targets investments in the healthcare industry. Areas within healthcare that Galen will consider include medical devices & technology, specialty pharmaceuticals, and information technology/services. Galen typically invests between $10 and $30 million per transaction in companies with a proprietary product or service that have attained revenues above $10 million. Prospective transactions include growth equity investments, complete buyouts, family business or other recapitalizations, going-private transactions, roll-overs of a portion of existing equity, and management buyouts. Galen Partners was formed in 1990 and is based in Stamford, Connecticut.
Join Mergr to view the latest updates and news from Stamford-based Galen Partners.
In the last 3 years, Galen Partners has acquired 2 companies.
Galen Partners’ most common sectors for investment are business services (25%) and healthcare services (25%). The Firm’s most common investment types include venture (47%) and buyout (lbo, mbo, mbi) (29%). In total, Galen Partners has invested in 14 US states and 2 different countries.
In the last 3 years, Galen Partners has exited 2 companies. The Firm’s most common exit type is trade sale (91%). Galen Partners’ largest (disclosed) exit occurred in 2004 when it sold Vitas Healthcare for $406M.
Join Mergr to view Galen Partners’ full profile and discover more large private equity firms just like it.
No obligation. Cancel anytime.